1. Home
  2. OVBC vs VYGR Comparison

OVBC vs VYGR Comparison

Compare OVBC & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ohio Valley Banc Corp.

OVBC

Ohio Valley Banc Corp.

HOLD

Current Price

$44.71

Market Cap

213.9M

Sector

Finance

ML Signal

HOLD

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

N/A

Current Price

$3.48

Market Cap

203.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OVBC
VYGR
Founded
1872
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
213.9M
203.6M
IPO Year
1996
2015

Fundamental Metrics

Financial Performance
Metric
OVBC
VYGR
Price
$44.71
$3.48
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$16.50
AVG Volume (30 Days)
34.6K
466.4K
Earning Date
04-28-2026
05-08-2026
Dividend Yield
2.22%
N/A
EPS Growth
42.67
N/A
EPS
1.53
N/A
Revenue
N/A
$10,135,000.00
Revenue This Year
N/A
$34.04
Revenue Next Year
N/A
$7.92
P/E Ratio
$29.54
N/A
Revenue Growth
N/A
N/A
52 Week Low
$34.18
$2.94
52 Week High
$51.25
$5.55

Technical Indicators

Market Signals
Indicator
OVBC
VYGR
Relative Strength Index (RSI) 58.55 62.99
Support Level $44.63 $3.29
Resistance Level $47.12 $4.31
Average True Range (ATR) 1.29 0.15
MACD 0.16 0.05
Stochastic Oscillator 75.52 93.88

Price Performance

Historical Comparison
OVBC
VYGR

About OVBC Ohio Valley Banc Corp.

Ohio Valley Banc Corporation is a financial holding company. The bank is a full-service financial institution offering a blend of commercial and consumer banking services in Southeastern Ohio and western West Virginia. The banking services offered by the bank include the acceptance of deposits in checking, savings, time and money market accounts; the making and servicing of personal, commercial, and student loans; and the making of construction and real estate loans. It also offers individual retirement accounts, safe deposit boxes, wire transfers, and other standard banking products and services.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.

Share on Social Networks: